Anyone who has experienced severe, chronic pain knows the long process it takes to get a correct diagnosis. Many people see an average of 5-6 specialists before getting a definitive diagnosis.

Currently, a fibromyalgia diagnosis is a "diagnosis of elimination" based on self-reported symptoms. And research suggests that, because of this fibromyalgia is often misdiagnosed and under diagnosed.

LOS ANGELES--(BUSINESS WIRE)--EpicGenetics, a privately held biomedical company dedicated to improving the diagnosis and treatment of fibromyalgia, today announced that the FM/a ® Test for ...

Ohio State University researchers have evidence that blood samples can reliably detect fibromyalgia, a disease that is often misdiagnosed due to its general symptoms that characterize a number of ...

For the first time, researchers have evidence that fibromyalgia can be reliably detected in blood samples—work they hope will pave the way for a simple, fast diagnosis. In a study that appears in the ...

Fibromyalgia is a long-term condition that involves widespread body pain. The pain happens along with fatigue. (Image generated using AI) One of the hardest conversations in rheumatology is not ...

Nashville-based data science company IQuity has announced the release of IsolateFibromyalgia ™, a pioneering blood test that uses RNA analysis to help health care providers accurately and quickly ...

Once dismissed by many clinicians, it is now estimated that as much as six percent of the world's population has fibromyalgia, a complex disease in which the body is affected by pain in the joints and ...

COLUMBUS, Ohio (WPVI) -- Ohio State University Wexner Medical Center has developed the first blood test for fibromyalgia, a condition at least 4 million people - mostly women, experience. Fibromyalgia ...

Fibromyalgia symptoms include widespread body pain, fatigue, unrefreshing sleep and mood problems. But all of these symptoms are common to many other conditions. And because fibromyalgia symptoms can ...

LOS ANGELES--(BUSINESS WIRE)--After analyzing thousands of patients, EpicGenetics today announced that its data shows that 80 percent of young people (under 19 years of age) who were tested for ...